228 related articles for article (PubMed ID: 18924160)
1. Pharmacogenetics of the neurodevelopmental impact of anticancer chemotherapy.
Robaey P; Krajinovic M; Marcoux S; Moghrabi A
Dev Disabil Res Rev; 2008; 14(3):211-20. PubMed ID: 18924160
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics for individualized cancer chemotherapy.
Efferth T; Volm M
Pharmacol Ther; 2005 Aug; 107(2):155-76. PubMed ID: 15890408
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacogenetics of anticancer drugs].
de Chaisemartin L; Loriot MA
Pathol Biol (Paris); 2005 Mar; 53(2):116-24. PubMed ID: 15708657
[TBL] [Abstract][Full Text] [Related]
4. Genetic tests for predicting the toxicity and efficacy of anticancer chemotherapy.
Mladosievicova B; Carter A; Kristova V
Neoplasma; 2007; 54(3):181-8. PubMed ID: 17447847
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetics in cancer treatment.
Nagasubramanian R; Innocenti F; Ratain MJ
Annu Rev Med; 2003; 54():437-52. PubMed ID: 12525681
[TBL] [Abstract][Full Text] [Related]
6. Neurocognitive effects of treatment for childhood cancer.
Butler RW; Haser JK
Ment Retard Dev Disabil Res Rev; 2006; 12(3):184-91. PubMed ID: 17061287
[TBL] [Abstract][Full Text] [Related]
7. Using genetic variation to optimize cancer chemotherapy.
McLeod HL; Papageorgio C; Watters JW
Clin Adv Hematol Oncol; 2003 Feb; 1(2):107-11. PubMed ID: 16224389
[TBL] [Abstract][Full Text] [Related]
8. Central neurotoxicity in cancer chemotherapy: pharmacogenetic insights.
Froklage FE; Reijneveld JC; Heimans JJ
Pharmacogenomics; 2011 Mar; 12(3):379-95. PubMed ID: 21449677
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomics of cancer chemotherapy-induced toxicity.
Miller CR; McLeod HL
J Support Oncol; 2007 Jan; 5(1):9-14. PubMed ID: 17265780
[TBL] [Abstract][Full Text] [Related]
10. Cancer pharmacogenetics: polymorphisms, pathways and beyond.
Ulrich CM; Robien K; McLeod HL
Nat Rev Cancer; 2003 Dec; 3(12):912-20. PubMed ID: 14740638
[No Abstract] [Full Text] [Related]
11. [Value and applications of pharmacogenetics in oncology and hematology].
Albin N; Massade L; Gouyette A
Bull Cancer; 1997 Jun; 84(6):643-51. PubMed ID: 9295869
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in the pharmacogenetics of cancer chemotherapy.
Watters JW; McLeod HL
Curr Opin Mol Ther; 2002 Dec; 4(6):565-71. PubMed ID: 12596358
[TBL] [Abstract][Full Text] [Related]
13. CYP450 pharmacogenetics for personalizing cancer therapy.
van Schaik RH
Drug Resist Updat; 2008 Jun; 11(3):77-98. PubMed ID: 18486526
[TBL] [Abstract][Full Text] [Related]
14. Advances in individual prediction of methotrexate toxicity: a review.
Schmiegelow K
Br J Haematol; 2009 Sep; 146(5):489-503. PubMed ID: 19538530
[TBL] [Abstract][Full Text] [Related]
15. Delayed neurotoxicity associated with therapy for children with acute lymphoblastic leukemia.
Cole PD; Kamen BA
Ment Retard Dev Disabil Res Rev; 2006; 12(3):174-83. PubMed ID: 17061283
[TBL] [Abstract][Full Text] [Related]
16. Cancer pharmacogenetics.
Marsh S
Methods Mol Biol; 2008; 448():437-46. PubMed ID: 18370241
[TBL] [Abstract][Full Text] [Related]
17. Pharmacology and pharmacogenetics of chemotherapeutic agents.
Dawood S; Leyland-Jones B
Cancer Invest; 2009 Jun; 27(5):482-8. PubMed ID: 19479485
[TBL] [Abstract][Full Text] [Related]
18. Genetic profiling can predict chemotherapy side effects and treatment response.
Expert Rev Mol Diagn; 2003 Jul; 3(4):406-7. PubMed ID: 12877380
[No Abstract] [Full Text] [Related]
19. Pharmacogenetics in gastrointestinal tumors.
Stöhlmacher J
Onkologie; 2005 Aug; 28(8-9):435-40. PubMed ID: 16160407
[TBL] [Abstract][Full Text] [Related]
20. [Anticancer drug dosing--pharmacogenomic biomarkers or body surface area?].
Lehne G; Bjørheim J; Saeter G
Tidsskr Nor Laegeforen; 2007 Apr; 127(8):1040-4. PubMed ID: 17457389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
